REFERENCES
- Yap YG, Camm J. Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause QT prolongation. Br Med J 2000; 320(7243)1158–1159
- Curtis LH, Ostbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Usdin Yasuda S, Dans PE, Wright A, Califf RM, Woosley RL, Schulman KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med 2003; 114(2)135–141, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marquardt K, Albertson TE. Treatment of hydroxychloroquine overdose. Am J Emerg Med 2001; 19(5)420–424, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jordan P, Brookes JG, Nikolic G, Le Couteur DG. Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol, Clin Toxicol 1999; 37(7)861–864, [CROSSREF]
- Isbister GK, Dawson A, Whyte IM. Hydroxychloroquine overdose: a prospective case series. Am J Emerg Med 2002; 20(4)377–378, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tett S, Cutler D, Day R. Antimalarials in rheumatic diseases. Clin Rheumatol 1990; 4(3)467–489
- Furst DE. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus 1996; 5(1)S11–S15, [PUBMED], [INFOTRIEVE]
- 8. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 1: Introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102(8 Suppl):I86–189